8HRX image
Entry Detail
PDB ID:
8HRX
EMDB ID:
Title:
Cryo-EM structure of human NTCP-myr-preS1-YN9048Fab complex
Biological Source:
PDB Version:
Deposition Date:
2022-12-16
Release Date:
2024-01-17
Method Details:
Experimental Method:
Resolution:
2.89 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Sodium/bile acid cotransporter
Chain IDs:A
Chain Length:343
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:PreS1 protein (Fragment)
Chain IDs:B
Chain Length:55
Number of Molecules:1
Biological Source:Hepatitis B virus
Polymer Type:polypeptide(L)
Description:Fab heavy chain from antibody IgG clone number YN9048
Chain IDs:C (auth: H)
Chain Length:246
Number of Molecules:1
Biological Source:Ondatra zibethicus
Polymer Type:polypeptide(L)
Description:Fab light chain from antibody IgG clone number YN9048
Chain IDs:D (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:Ondatra zibethicus
Ligand Molecules
Primary Citation
Structural basis of hepatitis B virus receptor binding.
Nat.Struct.Mol.Biol. 31 447 454 (2024)
PMID: 38233573 DOI: 10.1038/s41594-023-01191-5

Abstact

Hepatitis B virus (HBV), a leading cause of developing hepatocellular carcinoma affecting more than 290 million people worldwide, is an enveloped DNA virus specifically infecting hepatocytes. Myristoylated preS1 domain of the HBV large surface protein binds to the host receptor sodium-taurocholate cotransporting polypeptide (NTCP), a hepatocellular bile acid transporter, to initiate viral entry. Here, we report the cryogenic-electron microscopy structure of the myristoylated preS1 (residues 2-48) peptide bound to human NTCP. The unexpectedly folded N-terminal half of the peptide embeds deeply into the outward-facing tunnel of NTCP, whereas the C-terminal half formed extensive contacts on the extracellular surface. Our findings reveal an unprecedented induced-fit mechanism for establishing high-affinity virus-host attachment and provide a blueprint for the rational design of anti-HBV drugs targeting virus entry.

Legend

Protein

Chemical

Disease

Primary Citation of related structures